Supply Chain/Cold Chain

31. The Unique Challenges Facing Cannabis-based Pharma 1/2/2019

    Now that the FDA has finally approved the first-ever pharmaceutical derived from the cannabis plant, will drug development — and success — in this niche finally take off?

32. Germany’s Plan To Foster And Grow Biopharma Innovation 1/2/2019

    In Germany, bioclusters and technology parks have been created to encourage and support pharmaceutical innovation in the region.

33. Biopharma Bringing RWE Into The Real World 11/7/2018

    Real-world evidence is playing an increasingly important role throughout the drug development lifecycle—as outlined in Deloitte's latest survey on the life sciences industry's RWE capabilities— and companies are really beginning to take notice.

34. J&J’s QuickFire Challenges: Crowdsourcing Innovation 5/2/2018

    An in-depth look at J&J’s QuickFire Challenge program and how some of the winners have benefitted (and grown) beyond the cash grants.

35. 3 Operating Principles For Successful Drug Development 4/6/2018

    Can a culture with supporting systems that are simple, efficient, and effective significantly shorten drug development times? Why not?

36. Can A P3 Reduce Attrition Of Drug Candidates? 4/6/2018

    A look at a unique UK-based public-private partnership (P3), called Open Targets that was created to help companies choose better drug targets and reduce attrition of candidate drugs.

37. Intricate Supply Chain Complicates Gene Therapy Manufacturing 3/7/2018

    With the FDA’s approval of three new gene therapies, researchers and manufacturers must now figure out how streamline the development process.

38. GSK’s Bid To Accelerate Drug Discovery Using AI 3/7/2018

    GSK is looking to create a more efficient drug development system by integrating AI into its process.

39. Can AI Deliver Faster, Better Drug Development? 10/10/2017

    As the cost of developing new medicines continues to rise, more pharmaceutical companies are looking at how artificial intelligence (AI) can help in drug development. But there are some hurdles to overcome before its full potential is reached.

40. Preparing For A Blockchain-Enabled World 9/8/2017

    Ask life sciences industry leaders and experts about blockchain and you will hear it called everything from “a game changer” to “a major disrupter.” According to the hype, the technology behind cryptocurrencies, like bitcoin, is going to completely transform day-to-day operations for life sciences companies.